Chosa Oncology AB (XSAT:CHOSA) Accounts Payable: kr0.76 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:CHOSA Chosa Oncology AB XSAT:CHOSA
31 GF Score
Price kr0.79
View Full Analysis

What is Chosa Oncology AB Accounts Payable?

Chosa Oncology AB XSAT:CHOSA -0.50% 31 Accounts Payable is kr0.76 Mil as of Mar. 2026. GuruFocus rates XSAT:CHOSA with a GF Score™ of 31/100.

Chosa Oncology AB's Accounts Payable for the quarter that ended in Mar. 2026 was kr0.76 Mil.

Chosa Oncology AB's quarterly Accounts Payable increased from Sep. 2025 (kr0.14 Mil) to Dec. 2025 (kr2.71 Mil) but then declined from Dec. 2025 (kr2.71 Mil) to Mar. 2026 (kr0.76 Mil).

Chosa Oncology AB's annual Accounts Payable increased from Dec. 2023 (kr0.83 Mil) to Dec. 2024 (kr1.67 Mil) and increased from Dec. 2024 (kr1.67 Mil) to Dec. 2025 (kr2.71 Mil).

Chosa Oncology AB Accounts Payable Related Terms

Chosa Oncology AB Accounts Payable Historical Data

* Premium members only.

The historical data trend for Chosa Oncology AB's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chosa Oncology AB Accounts Payable Chart

Chosa Oncology AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.40 0.00 0.83 1.67 2.71

Chosa Oncology AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.24 0.57 0.14 2.71 0.76
XSAT:CHOSA
31GF Score
Chosa Oncology AB XSAT:CHOSA
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chosa Oncology AB Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of kr0.76 Mil mean?
Chosa Oncology AB (XSAT:CHOSA) has a Accounts Payable of kr0.76 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Chosa Oncology AB and its competitors.
Is Chosa Oncology AB's Accounts Payable too high?
Chosa Oncology AB's current Accounts Payable is kr0.76 Mil. Overall, Chosa Oncology AB has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Chosa Oncology AB's Accounts Payable compare to VRTX and REGN?
Chosa Oncology AB's Accounts Payable of kr0.76 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Chosa Oncology AB and its competitors. Chosa Oncology AB's current Accounts Payable is kr0.76 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chosa Oncology AB stock overvalued right now?
Chosa Oncology AB (XSAT:CHOSA) has a current Accounts Payable of kr0.76 Mil. The current Accounts Payable is kr0.76 Mil. Chosa Oncology AB's overall GF Score™ is 31/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Chosa Oncology AB (XSAT:CHOSA), the current Accounts Payable is kr0.76 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Chosa Oncology AB Business Description

Address Scheeletorget 1, Medicon Village, Lund, SWE, 223 81
Chosa Oncology AB is a biotechnology company engaged in the research and development in immunotherapy on therapeutic cancer vaccines.
31GF Score

Get the complete analysis for XSAT:CHOSA

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.79
Price